Current Protein Identity:P03354 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1A5V ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 AND MN CATION Deposited 1998-02-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Not recorded MN MANGANESE (II) ION × 2 Y3 4-ACETYLAMINO-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA HEPES, PH 7.5
Resolution 1.90 Å R-free 0.210
1A5V ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 AND MN CATION Deposited 1998-02-18 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Not recorded MN MANGANESE (II) ION × 2 Y3 4-ACETYLAMINO-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA HEPES, PH 7.5
Resolution 1.90 Å R-free 0.210
1A5W ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 Deposited 1998-02-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Not recorded Y3 4-ACETYLAMINO-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA CITRATE PH 5.6
Resolution 2.00 Å R-free 0.222
1A5X ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 Deposited 1998-02-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Not recorded Y3 4-ACETYLAMINO-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;20% PEG 4000, 10% ISOPROPANOL, 0.1M HEPES, PH 7.5
Resolution 1.90 Å R-free 0.212
1ASU AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 2% PEG 400, 2M AMMONIUM SULFATE, HEPES PH 7.5 Deposited 1995-08-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa)
Mutation:INS(PRO 48, LEU 49, ARG 50, GLU 51, ASN 208, LEU 209) EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5
Resolution 1.70 Å R-free 0.188
1ASV Avian sarcoma virus integrase catalytic core domain Deposited 1995-08-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa)
Mutation:INS(PRO 48, LEU 49, ARG 50, GLU 51, ASN 208, LEU 209) Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;pH 5.6
Resolution 2.20 Å R-free 0.234
1ASW AVIAN SARCOMA VIRUS INTEGRASE CATALYTIC CORE DOMAIN CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, HEPES PH 7.5 USING SELENOMETHIONINE SUBSTITUTED PROTEIN; DATA COLLECTED AT-165 DEGREES C Deposited 1995-08-25 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa)
Mutation:INS(PRO 48, LEU 49, ARG 50, GLU 51, ASN 208, LEU 209) Non-standard monomer:Yes (specific site not provided by mmCIF) EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 IPA ISOPROPYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5
Resolution 1.80 Å R-free 0.208
1C0M CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE Deposited 1999-07-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 621–858(238 aa) Fragment:RESIDUES 49-286
Chain B 621–858(238 aa) Fragment:RESIDUES 49-286
Mutation:F199K Mutation:F199K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions HANGING DROP VAPOR DIFFUSION METHOD;pH 7;277 K;PLATE-SHAPED CRYSTALS WERE INFREQUENTLY GROWN BY HANGING DROP VAPOR DIFFUSION METHOD. RESERVOIR SOLUTION CONTAINED 0.050M KCL, 0.01M MGCL2, 0.05M SODIUM CACODYLATE, PH 7.0, 10% PEG 3350, and 20% (V/V) ETHYLENE GLYCOL. THE DROP CONTAINED 1:1 MIXTURE OF RESERVOIR SOLUTION AND PROTEIN (10-15 MG/ML), HANGING DROP VAPOR DIFFUSION METHOD, temperature 277K
Resolution 2.53 Å R-free 0.279
1C0M CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE Deposited 1999-07-16 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 621–858(238 aa) Fragment:RESIDUES 49-286
Chain D 621–858(238 aa) Fragment:RESIDUES 49-286
Mutation:F199K Mutation:F199K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions HANGING DROP VAPOR DIFFUSION METHOD;pH 7;277 K;PLATE-SHAPED CRYSTALS WERE INFREQUENTLY GROWN BY HANGING DROP VAPOR DIFFUSION METHOD. RESERVOIR SOLUTION CONTAINED 0.050M KCL, 0.01M MGCL2, 0.05M SODIUM CACODYLATE, PH 7.0, 10% PEG 3350, and 20% (V/V) ETHYLENE GLYCOL. THE DROP CONTAINED 1:1 MIXTURE OF RESERVOIR SOLUTION AND PROTEIN (10-15 MG/ML), HANGING DROP VAPOR DIFFUSION METHOD, temperature 277K
Resolution 2.53 Å R-free 0.279
1C1A CRYSTAL STRUCTURE OF RSV TWO-DOMAIN INTEGRASE Deposited 1999-07-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 621–858(238 aa) Fragment:RESIDUES 49-286
Chain B 621–858(238 aa) Fragment:RESIDUES 49-286
Mutation:F199K Mutation:F199K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions ROD-SHAPED CRYSTALS WERE GROWN BY SITTING DROP VAPOR DIFFUSION METHOD. RESERVOIR SOLUTION CONTAINED 0.050M KCL, 0.01M MGCL2, 0.1M SODIUM CACODYLATE, 0.02M IMIDAZOLE, PH 7.2, 10% PEG3350, AND 20% (V/V) ETHYLENE GLYCOL. THE DROP CONTAINED 1:1 MIXTURE OF RESERVOIR SOLUTION AND PROTEIN (10-15 MG/ML)
Resolution 3.10 Å R-free 0.337
1CXQ ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM AMMONIUM SULFATE Deposited 1999-08-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:INS(P48, L49, R50, E51, N208, L209) EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 GOL GLYCEROL × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;2% Peg 400, 2M Ammonium Sulfate, HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 1.02 Å R-free 0.157
1CXU 1.42A RESOLUTION ASV INTEGRASE CORE DOMAIN FROM CITRATE Deposited 1999-08-30 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:INS(P48, L49, R50, E51, N208, L209) CIT CITRIC ACID × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.2;277 K;20% PEG 4000, 10% ISOPROPANOL, 100 MM CITRATE, PH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.42 Å R-free 0.221
1CZ9 ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN (D64N) FROM CITRATE Deposited 1999-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:D64N, INS(P48, L49, R50, E51, N208, L209) SO4 SULFATE ION × 2 CIT CITRIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.2;277 K;20% PEG 4000, 10% ISOPROPANOL, 100 MM CITRATE PH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 1.20 Å R-free 0.150
1CZB ATOMIC RESOLUTION ASV INTEGRASE CORE DOMAIN FROM HEPES Deposited 1999-09-01 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 624–779(156 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:INS(P48, L49, R50, E51, N208, L209) EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;20% PEG 4000, 10% ISOPROPANOL, 100 mM HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.06 Å R-free 0.164
1VSD ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM Deposited 1995-11-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 616–771(156 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Non-standard monomer:Yes (specific site not provided by mmCIF) MG MAGNESIUM ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5 THE PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, 100 MILLI-MOLAR HEPES PH 7.5. CRYSTALS WERE THEN SOAKED IN 500 MILLI-MOLAR MGCL2.
Resolution 1.70 Å R-free 0.191
1VSE ASV INTEGRASE CORE DOMAIN WITH MG(II) COFACTOR AND HEPES LIGAND, LOW MG CONCENTRATION FORM Deposited 1995-11-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Not recorded EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5 THE PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, 100 MILLIMOLAR HEPES PH 7.5. CRYSTALS WERE THEN SOAKED IN 20 MILLIMOLAR MGCL2.
Resolution 2.20 Å R-free 0.201
1VSF ASV INTEGRASE CORE DOMAIN WITH MN(II) COFACTOR AND HEPES LIGAND, HIGH MG CONCENTRATION FORM Deposited 1995-11-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Not recorded MN MANGANESE (II) ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;pH 7.5 THE PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, 100 MILLIMOLAR HEPES PH 7.5. CRYSTALS WERE THEN SOAKED IN 10 MILLIMOLAR MNCL2.
Resolution 2.05 Å R-free 0.189
1VSH ASV INTEGRASE CORE DOMAIN WITH ZN(II) COFACTORS Deposited 1997-03-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 8 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, 100 MM HEPES, PH 7.5, THEN SOAKED IN 100 MM ZNCL2.
Resolution 1.95 Å
1VSI ASV INTEGRASE CORE DOMAIN WITH CA(II) COFACTOR Deposited 1997-03-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Non-standard monomer:Yes (specific site not provided by mmCIF) CA CALCIUM ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, 10% ISOPROPANOL, 100 MM HEPES, PH 7.5, THEN SOAKED IN 100 MM CACL2.
Resolution 2.20 Å
1VSJ ASV INTEGRASE CORE DOMAIN WITH CD(II) COFACTORS Deposited 1997-03-04 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN, RESIDUES 1 - 4, 52 - 209
Non-standard monomer:Yes (specific site not provided by mmCIF) CD CADMIUM ION × 4 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;PROTEIN WAS CRYSTALLIZED FROM 20% PEG 4000, N10% ISOPROPANOL, 100 MM HEPES, PH 7.5, THEN SOAKED IN 100 MM CDCL2.
Resolution 2.10 Å
1VSK ASV INTEGRASE CORE DOMAIN D64N MUTATION IN CITRATE BUFFER PH 6.0 Deposited 1998-09-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:D64N No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA CITRATE PH 5.6
Resolution 2.20 Å R-free 0.249
1VSL ASV INTEGRASE CORE DOMAIN D64N MUTATION WITH ZINC CATION Deposited 1998-09-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN
Mutation:D64N ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA CITRATE PH 5.6
Resolution 2.20 Å R-free 0.244
1VSM ASV INTEGRASE CORE DOMAIN IN CITRATE BUFFER PH 5.0 Deposited 1998-09-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 626–771(146 aa) Fragment:CATALYTIC CORE DOMAIN
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.6;20% PEG 4000, 10% ISOPROPANOL, 0.1M NA CITRATE PH 5.0, pH 5.6
Resolution 2.15 Å R-free 0.238
3TIR Pseudo-atomic model of the Rous Sarcoma Virus capsid hexamer Deposited 2011-08-21 Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 240–465(226 aa) Fragment:UNP resides 240-465
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 10.3;291.15 K;2-7 %(w/v) PEG 8000 0.2M CAPS/KOH, pH 10.3, VAPOR DIFFUSION, SITTING DROP, temperature 291.15K
Resolution 4.10 Å R-free 0.391
4FW1 Crystal structure of two-domain RSV INTEGRASE covalently linked with DNA Deposited 2012-06-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1329–1550(222 aa) Fragment:UNP residues 1329-1580
Chain B 1329–1550(222 aa) Fragment:UNP residues 1329-1580
Mutation:S124D, C125A, E157C, R166K, F199K Mutation:S124D, C125A, E157C, R166K, F199K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;5% Ethanol, 10% PEG4,000, 100mM Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 1.86 Å R-free 0.222
4FW2 Crystal structure of RSV three-domain integrase with disordered N-terminal domain Deposited 2012-06-29 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1281–1550(270 aa) Fragment:UNP residues 1281-1550
Chain B 1281–1550(270 aa) Fragment:UNP residues 1281-1550
Mutation:C23S, R166K, F199K Mutation:C23S, R166K, F199K No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;20% ethanol, 100 mM imidazole-HCl, and 5% PEG4000, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.65 Å R-free 0.244
5EJK Crystal structure of the Rous sarcoma virus intasome Deposited 2015-11-02 Assembly 1 Protein–DNA Homooligomer;Protein × 8 PDB declaration: hexadecameric(16) Consistent with all polymers
Chain A 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain B 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain C 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain D 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain E 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain F 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain G 1281–1550(270 aa) Fragment:UNP residues 573-842
Chain H 1281–1550(270 aa) Fragment:UNP residues 573-842
Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:C23S, L112M, L135M, L162M, L163M, L188 M, L189M Non-standard monomer:Yes (specific site not provided by mmCIF) ZN ZINC ION × 8 W TUNGSTEN ION × 36 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;293 K;Sodium formate
Resolution 3.80 Å R-free 0.294
5KZ9 Crystal structure of the Rous sarcoma virus matrix protein. Deposited 2016-07-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–155(155 aa) Fragment:UNP residues 1-155
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 10.3;293 K;2.60 M Ammonium formate, 0.20 M Beta-Alanine/KOH pH 10.3
Resolution 2.85 Å R-free 0.239
5KZ9 Crystal structure of the Rous sarcoma virus matrix protein. Deposited 2016-07-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1–155(155 aa) Fragment:UNP residues 1-155
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 10.3;293 K;2.60 M Ammonium formate, 0.20 M Beta-Alanine/KOH pH 10.3
Resolution 2.85 Å R-free 0.239
5KZA Crystal structure of the Rous sarcoma virus matrix protein (aa 2-102). Space group I41 Deposited 2016-07-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–102(101 aa) Fragment:UNP residues 2-102
Not recorded NO3 NITRATE ION × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.15 K;18%(w/v) PEG 8000, 0.2 M Succinic acid/KOH pH 5.5, 1.0 M Ammonium nitrate
Resolution 1.86 Å R-free 0.210
5KZA Crystal structure of the Rous sarcoma virus matrix protein (aa 2-102). Space group I41 Deposited 2016-07-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 2–102(101 aa) Fragment:UNP residues 2-102
Not recorded NO3 NITRATE ION × 4 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.15 K;18%(w/v) PEG 8000, 0.2 M Succinic acid/KOH pH 5.5, 1.0 M Ammonium nitrate
Resolution 1.86 Å R-free 0.210
5KZB Crystal structure of the Rous sarcoma virus matrix protein (aa 2-102). Space group I4122 Deposited 2016-07-24 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–102(101 aa) Fragment:UNP residues 2-102
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.1;291.15 K;0.6 M Malonic acid /KOH pH 9.1, 0.1 M Boric acid /KOH pH 9.1
Resolution 3.20 Å R-free 0.249
5KZB Crystal structure of the Rous sarcoma virus matrix protein (aa 2-102). Space group I4122 Deposited 2016-07-24 Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 2–102(101 aa) Fragment:UNP residues 2-102
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.1;291.15 K;0.6 M Malonic acid /KOH pH 9.1, 0.1 M Boric acid /KOH pH 9.1
Resolution 3.20 Å R-free 0.249
6CCJ NMR structure of the Rous sarcoma virus matrix protein (M domain) Deposited 2018-02-07 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–87(86 aa)
Mutation:M1S No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;305 K;Ionic strength (raw mmCIF value) 0.1;Pressure 1
NMR sample composition 0.5 mM [U-95% 13C; U-95% 15N] RSV MA, 50 mM sodium phosphate, 50 mM sodium chloride, 2 mM TCEP, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition .5 mM [U-95% 15N] Matrix protein, 50 mM sodium phosphate, 50 mM sodium chloride, 2 M TCEP, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.5 mM [U-95% 13C] Matrix protein, 50 mM sodium phosphate, 50 mM sodium chloride, 2 mM TCEP, 100% D2O | 100% D2O
Resolution not provided
6CE5 NMR structure of the Rous sarcoma virus matrix protein (M-domain) in the presence of myo-inositol hexakisphosphate Deposited 2018-02-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–87(87 aa)
Mutation:M1S No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;305 K;Ionic strength (raw mmCIF value) 0.05;Pressure 1
NMR sample composition 0.5 mM [U-95% 15N] Matrix protein, 50 mM sodium phosphate, 2 mM tcep, 2 mM IP6, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.5 mM [U-95% 13C; U-95% 15N] Matrix protein, 50 mM sodium phosphate, 2 mM tcep, 2 mM IP6, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
6CUS HADDOCK structure of the Rous sarcoma virus matrix protein (M-domain) in complex with myo-inositol hexakisphosphate Deposited 2018-03-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–87(87 aa)
Mutation:M1S IHP INOSITOL HEXAKISPHOSPHATE × 1 SOLUTION NMR
NMR measurement conditions pH 6;305 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition 500 uM [U-98% 15N] Matrix protein, 50 mM sodium phosphate, 2 mM TCEP, 2 mM INOSITOL HEXAKISPHOSPHATE, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition 0.5 mM [U-98% 13C] Matrix protein, 50 mM sodium phosphate, 2 mM TCEP, 2 mM INOSITOL HEXAKISPHOSPHATE, 100% D2O | 100% D2O
Resolution not provided
6CV8 HADDOCK structure of the Rous sarcoma virus matrix protein (M-domain) in complex with inositol 1,4,5-trisphosphate Deposited 2018-03-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–87(87 aa)
Mutation:M1S I3P D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE × 1 SOLUTION NMR
NMR measurement conditions pH 6;305 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition 100 uM [U-98% 15N] Matrix protein, 50 mM sodium phosphate, 2 mM TCEP, 1.6 mM D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
6CW4 HADDOCK structure of the Rous sarcoma virus matrix protein (M-domain) in complex with inositol 1,3,5-trisphosphate Deposited 2018-03-29 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–87(87 aa) Fragment:residues 1-87
Mutation:M1S FGV (1R,2S,3r,4R,5S,6s)-2,4,6-trihydroxycyclohexane-1,3,5-triyl tris[dihydrogen (phosphate)] × 1 SOLUTION NMR
NMR measurement conditions pH 6;305 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition 100 uM [U-98% 15N] Matrix protein, 50 mM sodium phosphate, 2 mM TCEP, 1.6 mM IP3, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
7JN3 Cryo-EM structure of Rous sarcoma virus cleaved synaptic complex (CSC) with HIV-1 integrase strand transfer inhibitor MK-2048 Deposited 2020-08-03 Assembly 1 Protein–DNA Homooligomer;Protein × 8 PDB declaration: dodecameric(12) Consistent with all polymers
Chain A 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain B 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain C 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain D 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain E 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain F 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain G 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain H 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Not recorded ZN ZINC ION × 2 ZZX (6S)-2-(3-chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide × 2 MG MAGNESIUM ION × 4 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.21 Å
7KU7 Cryo-EM structure of Rous sarcoma virus cleaved synaptic complex (CSC) with HIV-1 integrase strand transfer inhibitor MK-2048. Cluster identified by 3-dimensional variability analysis in cryoSPARC. Deposited 2020-11-24 Assembly 1 Protein–DNA Homooligomer;Protein × 8 PDB declaration: dodecameric(12) Consistent with all polymers
Chain A 1281–1558(278 aa)
Chain B 1281–1558(278 aa)
Chain C 1281–1558(278 aa)
Chain D 1281–1558(278 aa)
Chain E 1281–1558(278 aa)
Chain F 1281–1558(278 aa)
Chain G 1281–1558(278 aa)
Chain H 1281–1558(278 aa)
Not recorded ZN ZINC ION × 2 MG MAGNESIUM ION × 4 ZZX (6S)-2-(3-chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
7KUI Cryo-EM structure of Rous sarcoma virus cleaved synaptic complex (CSC) with HIV-1 integrase strand transfer inhibitor MK-2048. CIC region of a cluster identified by 3-dimensional variability analysis in cryoSPARC. Deposited 2020-11-25 Assembly 1 Protein–DNA Homooligomer;Protein × 8 PDB declaration: dodecameric(12) Consistent with all polymers
Chain A 1281–1558(278 aa)
Chain B 1281–1558(278 aa)
Chain C 1281–1558(278 aa)
Chain D 1281–1558(278 aa)
Chain E 1281–1558(278 aa)
Chain F 1281–1558(278 aa)
Chain G 1281–1558(278 aa)
Chain H 1281–1558(278 aa)
Not recorded ZN ZINC ION × 2 ZZX (6S)-2-(3-chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.40 Å
8E14 Cryo-EM structure of Rous sarcoma virus strand transfer complex Deposited 2022-08-09 Assembly 1 Protein–DNA Homooligomer;Protein × 8 PDB declaration: tetradecameric(14) Consistent with all polymers
Chain A 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain B 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain C 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain D 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain E 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain F 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain G 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Chain H 1281–1558(278 aa) Fragment:UNP residues 1281-1558
Not recorded ZN ZINC ION × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.36 Å